SuO-Val-Cit-PAB-MMAE
This ADC linker incorporates the cytotoxic payload MMAE, a potent tubulin inhibitor, via a protease-cleavable SuO-Val-Cit-PAB peptide sequence. It is widely used in the development of antibody-drug conjugates for targeted cancer therapy research, enabling the study of drug delivery and efficacy in both in vitro and in vivo models.
Product Specifications
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Smiles
CC[C@H] (C) [C@@H] ([C@@H] (CC (N1[C@@H] (CCC1) [C@@H] ([C@@H] (C) C (N[C@H] (C) [C@@H] (O) C2=CC=CC=C2) =O) OC) =O) OC) N (C ([C@H] (C (C) C) NC ([C@H] (C (C) C) N (C (OCC3=CC=C (NC ([C@H] (CCCNC (N) =O) NC ([C@H] (C (C) C) NC (ON4C (CCC4=O) =O) =O) =O) =O) C=C3) =O) C) =O) =O) C
Molecular Formula
C63H97N11O16
Molecular Weight
1264.51
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
